Skip to search boxSkip to navigationSkip to main content

Conjunctival ultraviolet autofluorescence as a biomarker of outdoor exposure in myopia: a systematic review and meta-analysis

  • Natali Gutierrez Rodriguez
    ,
  • Aura Ortega Claici
    ,
  • Jorge A. Ramos-Castaneda
    ,
  • Jorge González-Zamora
    ,
  • Valentina Bilbao-Malavé
    ,
  • Miriam de la Puente
*Corresponding author for this work
  • Universidad Antonio Nariño
    ,
  • University of Navarra
    ,
  • Navarra Medical Research Institute
    ,
  • Bellvitge University Hospital
    ,
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication metrics

Metrics

SciVal
FWCI
0.77
SciVal
Author count
10
SciVal
Paper percentile
64
SciVal
Citations
8
Scopus
Citations

Abstract

Outdoor exposure is considered the primary modifiable risk factor in preventing the development of myopia. This effect is thought to be attributed to the light-induced synthesis and release of dopamine in the retina. However, until recent years, there was no objective quantifiable method available to measure the association between time spent outdoors and myopia. It is only recently that the conjunctival ultraviolet autofluorescence (CUVAF) area, serving as a biomarker for sun exposure, has begun to be utilized in numerous studies. To provide a comprehensive summary of the relevant evidence pertaining to the association between the CUVAF area and myopia across different geographic regions and age groups, a systematic review and meta-analysis were conducted. The search encompassed multiple databases, including MEDLINE, SCIENCE DIRECT, GOOGLE SCHOLAR, WEB OF SCIENCE, and SCOPUS, and utilized specific search terms such as "conjunctival ultraviolet autofluorescence", "CUVAF", "UVAF", "objective marker of ocular sun exposure", "myopia", "degenerative myopia", and "high myopia". The bibliographic research included papers published between the years 2006 and 2022. A total of 4051 records were initially identified, and after duplicates were removed, 49 articles underwent full-text review. Nine articles were included in the systematic review. These studies covered myopia and outdoor exposure across different regions (Australia, Europe and India) with a total population of 3615 individuals. They found that myopes generally had smaller CUVAF areas compared to non-myopes. The meta-analysis confirmed this, revealing statistically smaller CUVAF areas in myopic patients, with a mean difference of − 3.30 mm2 (95% CI − 5.53; − 1.06). Additionally, some studies showed a positive correlation between more outdoor exposure and larger CUVAF areas. In terms of outdoor exposure time, myopic patients reported less time outdoors than non-myopic individuals, with a mean difference of − 3.38 h/week (95% CI − 4.66; − 2.09). Overall, these findings highlight the connection between outdoor exposure, CUVAF area and myopia, with regional variations playing a significant role. The results of this meta-analysis validate CUVAF as a quantitative method to objectively measure outdoor exposure in relation with myopia development.

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

1097

Pages from-to (Number of pages)

Pages 1097

Journal (Volume, Issue Number)

Scientific Reports (Volume 14, Issue 1)

Publication milestones

  • Published - 12/2024

Publication status

Published - 12/2024

ISSN

2045-2322

Publication IDs

  • Scopus: 85182097021
  • PubMed: 38212604

Funding Details

This work has been funded by Instituto de Salud Carlos III through the project “PI20/00251” Co-funded by European Regional Development Fund “A way to make Europe”; Fundación Jesús Gangoiti Barrera (2020-2021) and a collaborative project with Multiópticas (CUN 2019). Moreover, the work was partially supported by Redes de Investigación Cooperativa Orientadas al Resultado en Salud (RICORS) de Terapias avanzadas (RD21/0017/0027), Enfermedades Inflamatorias (RD21/0002/0010) y Enfermedades vasculares cerebrales (RD21/0006/0008), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain. Doctoral fellowship funded by Miniciencias Bogotá, Colombia.
FundersFunding numbers
Enfermedades Inflamatorias
RD21/0006/0008, RD21/0002/0010
Fundación Jesús Gangoiti Barrera
2020-2021, CUN 2019
Redes de Investigación Cooperativa Orientadas al Resultado en Salud
RD21/0017/0027
MCIU
-
ISCIII
PI20/00251
ISCIII
-
ERDF
-